Denali Therapeutics Inc. (9)

Browse by Contract Category

Contracts

Common Stock Purchase Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
Provisional LRRK2 Collaboration and License Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
Definitive R (Filed With SEC on November 5, 2020)
Form of Amended and Restated Change in Control and Severance Plan (Filed With SEC on November 5, 2020)
Standstill and Stock Restriction Agreement between the Registrant and Biogen Inc., dated September 22, 2020 (Filed With SEC on November 5, 2020)
Definitive LRRK2 Collaboration and License Agreement (Filed With SEC on November 5, 2020)
Amended and Restated Outside Director Compensation Policy (Filed With SEC on May 7, 2020)
Description of the registrants common stock (Filed With SEC on February 27, 2020)
Underwriting Agreement, dated as of January 28, 2020, among Denali Therapeutics Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Jefferies LLC, as representatives... (Filed With SEC on January 29, 2020)